CVRx/$CVRX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About CVRx
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.
Ticker
$CVRX
Sector
Primary listing
Employees
223
Headquarters
Website
CVRx Metrics
BasicAdvanced
$229M
-
-$2.04
1.28
-
Price and volume
Market cap
$229M
Beta
1.28
52-week high
$13.34
52-week low
$4.30
Average daily volume
368K
Financial strength
Current ratio
7.633
Quick ratio
6.486
Long term debt to equity
127.535
Total debt to equity
128.43
Interest coverage (TTM)
-8.80%
Profitability
EBITDA (TTM)
-50.509
Gross margin (TTM)
85.33%
Net profit margin (TTM)
-94.10%
Operating margin (TTM)
-90.49%
Effective tax rate (TTM)
0.03%
Revenue per employee (TTM)
$250,000
Management effectiveness
Return on assets (TTM)
-26.90%
Return on equity (TTM)
-96.59%
Valuation
Price to revenue (TTM)
4.001
Price to book
5.81
Price to tangible book (TTM)
5.81
Price to free cash flow (TTM)
-5.563
Free cash flow yield (TTM)
-17.98%
Free cash flow per share (TTM)
-1.562
Growth
Revenue change (TTM)
10.45%
Earnings per share change (TTM)
-22.99%
3-year revenue growth (CAGR)
36.11%
3-year earnings per share growth (CAGR)
0.43%
What the Analysts think about CVRx
Analyst ratings (Buy, Hold, Sell) for CVRx stock.
CVRx Financial Performance
Revenues and expenses
CVRx Earnings Performance
Company profitability
CVRx News
AllArticlesVideos
Securities Fraud Investigation Into CVRx, Inc. (CVRX) Continues – Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz
Business Wire·4 days ago
CVRx, Inc. (CVRX) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
Business Wire·4 days ago
Securities Fraud Investigation Into CVRx, Inc. (CVRX) Announced – Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz
Business Wire·4 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for CVRx stock?
CVRx (CVRX) has a market cap of $229M as of March 21, 2026.
What is the P/E ratio for CVRx stock?
The price to earnings (P/E) ratio for CVRx (CVRX) stock is 0 as of March 21, 2026.
Does CVRx stock pay dividends?
No, CVRx (CVRX) stock does not pay dividends to its shareholders as of March 21, 2026.
When is the next CVRx dividend payment date?
CVRx (CVRX) stock does not pay dividends to its shareholders.
What is the beta indicator for CVRx?
CVRx (CVRX) has a beta rating of 1.28. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.